Birchview Capital as of March 31, 2020
Portfolio Holdings for Birchview Capital
Birchview Capital holds 46 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 38.9 | $44M | 786k | 55.74 | |
| Accelr8 Technology | 16.2 | $18M | 2.2M | 8.33 | |
| Neurocrine Biosciences (NBIX) | 5.7 | $6.4M | 74k | 86.55 | |
| Quidel Corporation | 4.2 | $4.8M | 49k | 97.80 | |
| ACADIA Pharmaceuticals (ACAD) | 3.4 | $3.9M | 92k | 42.25 | |
| Biogen Idec (BIIB) | 3.1 | $3.5M | 11k | 316.36 | |
| Karyopharm Therapeutics | 2.5 | $2.8M | 148k | 19.21 | |
| Rts/bristol-myers Squibb Compa | 2.4 | $2.7M | 707k | 3.80 | |
| Vermillion | 2.4 | $2.7M | 3.2M | 0.83 | |
| United Therapeutics Corporation (UTHR) | 1.5 | $1.7M | 18k | 94.83 | |
| Acceleron Pharma | 1.5 | $1.7M | 19k | 89.87 | |
| Oxford Immunotec Global | 1.4 | $1.6M | 170k | 9.26 | |
| Gilead Sciences (GILD) | 1.3 | $1.5M | 20k | 74.75 | |
| Contrafect | 1.3 | $1.5M | 256k | 5.76 | |
| Masimo Corporation (MASI) | 1.3 | $1.4M | 8.0k | 177.12 | |
| Chemocentryx | 1.1 | $1.2M | 30k | 40.17 | |
| Epizyme | 0.8 | $931k | 60k | 15.52 | |
| Arena Pharmaceuticals | 0.8 | $924k | 22k | 42.00 | |
| Vanda Pharmaceuticals (VNDA) | 0.7 | $829k | 80k | 10.36 | |
| Albireo Pharma | 0.7 | $786k | 48k | 16.38 | |
| Amarin Corporation | 0.6 | $720k | 180k | 4.00 | |
| Harrow Health (HROW) | 0.6 | $688k | 180k | 3.82 | |
| ImmunoGen | 0.6 | $648k | 190k | 3.41 | |
| Eqt Midstream Partners | 0.5 | $605k | 51k | 11.80 | |
| Arvinas Ord (ARVN) | 0.5 | $604k | 15k | 40.27 | |
| Corcept Therapeutics Incorporated (CORT) | 0.5 | $594k | 50k | 11.88 | |
| Odonate Therapeutics Ord | 0.5 | $552k | 20k | 27.60 | |
| Intercept Pharmaceuticals In | 0.5 | $523k | 8.3k | 63.01 | |
| Soleno Therapeutics | 0.4 | $480k | 202k | 2.38 | |
| Stoke Therapeutics (STOK) | 0.4 | $458k | 20k | 22.90 | |
| G1 Therapeutics | 0.4 | $441k | 40k | 11.03 | |
| Inflarx Nv (IFRX) | 0.4 | $420k | 110k | 3.82 | |
| Xencor (XNCR) | 0.3 | $368k | 12k | 29.92 | |
| Amicus Therapeutics (FOLD) | 0.3 | $351k | 38k | 9.24 | |
| Biohaven Pharmaceutical Holding | 0.3 | $340k | 10k | 34.00 | |
| Progyny (PGNY) | 0.3 | $318k | 15k | 21.20 | |
| Translate Bio | 0.3 | $299k | 30k | 9.97 | |
| Voyager Therapeutics (VYGR) | 0.2 | $274k | 30k | 9.13 | |
| Pioneer Natural Resources | 0.2 | $267k | 3.8k | 70.26 | |
| Kalvista Pharmaceuticals (KALV) | 0.2 | $230k | 30k | 7.67 | |
| Apellis Pharmaceuticals (APLS) | 0.2 | $214k | 8.0k | 26.75 | |
| Dicerna Pharmaceuticals | 0.2 | $184k | 10k | 18.40 | |
| Tg Therapeutics (TGTX) | 0.1 | $148k | 15k | 9.87 | |
| Yield10 Bioscience | 0.1 | $71k | 19k | 3.75 | |
| Workhorse Group Inc ordinary shares | 0.0 | $45k | 25k | 1.80 | |
| BioCryst Pharmaceuticals (BCRX) | 0.0 | $40k | 20k | 2.00 |
